Listed

Larimar Therapeutics, Inc.

LRMRNasdaqCIK 1374690HealthcareFiscal year ends Dec 31

Reports and events: 239 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Larimar Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2021-08-1210:28 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-043701
2021-07-0217:08 ETSC 13D/AOwnership report, active investor, amended0001193805-21-000975
2021-07-0106:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-205474
2021-06-1417:21 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-190213
2021-05-2613:48 ETSC 13D/AOwnership report, active investor, amended0001193805-21-000725
2021-05-2610:17 ET8-K1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-173167
2021-05-2117:05 ETSC 13D/AOwnership report, active investor, amended0001193805-21-000700
2021-05-2109:30 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-21-168704
2021-05-2107:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-168548
2021-05-1815:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-165178
2021-05-1706:08 ET8-K5.07 Shareholder vote results0001193125-21-162647
2021-05-1108:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-157048
2021-05-1016:30 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-026084
2021-05-1016:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-156249
2021-04-1409:08 ETDEF 14AProxy statementPeriod 2021-05-120001193125-21-115586
2021-03-0417:16 ET8-K/A9.01 Financial statements and exhibits0001193125-21-069725
2021-03-0417:09 ET10-KAnnual reportPeriod 2020-12-310001564590-21-011003
2021-03-0407:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-068478
2020-12-0807:40 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-312288
2020-11-1216:51 ET8-K/A9.01 Financial statements and exhibits0001193125-20-291777
2020-11-1216:41 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-053618
2020-11-1016:23 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-290185
2020-10-3017:02 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-282731
2020-09-2916:39 ET8-K/A5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-257868
2020-09-2907:06 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-257168
2020-08-1906:08 ETDEF 14AProxy statementPeriod 2020-09-290001193125-20-224087
2020-08-1416:56 ET8-K/A9.01 Financial statements and exhibits0001193125-20-220561
2020-08-1416:48 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-040314
2020-08-1107:38 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-215639
2020-08-0609:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-211426
2020-07-0116:01 ETSC 13D/AOwnership report, active investor, amended0001193805-20-000766
2020-06-3016:46 ETSC 13D/AOwnership report, active investor, amended0001193125-20-184105
2020-06-2617:08 ET8-K/A8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-181113
2020-06-0817:21 ETSC 13DOwnership report, active investor0001193125-20-163701
2020-06-0817:10 ETSC 13DOwnership report, active investor0001193805-20-000670
2020-06-0321:27 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-158916
2020-06-0207:49 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-20-157924
2020-05-0716:38 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-022942
2020-04-2417:01 ET8-K3.01 Delisting notice0001193125-20-119225
2020-03-0918:09 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-065288
2020-03-0516:31 ET10-KAnnual reportPeriod 2019-12-310001564590-20-008984
2020-03-0516:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-063097
2020-02-0516:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-025413
2020-01-1307:17 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-005893
2019-12-2709:25 ETSC 13DOwnership report, active investor0001193125-19-325057
2019-12-1808:13 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.01 Change in control; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-316828
2019-11-0616:40 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-041090
2019-11-0616:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-285939
2019-09-1917:00 ET8-K3.01 Delisting notice0001193125-19-249639
2019-09-1217:19 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-19-244019

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.